Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 44,000 | 44,000 | 47,000 | 46,000 | 45,000 |
| Gross Profit | -44,000 | -44,000 | -47,000 | -46,000 | -45,000 |
| Selling General And Administration | 434,000 | 3.3M | 467,000 | 3.1M | 395,000 |
| General And Administrative Expense | 434,000 | 3.3M | 467,000 | 3.1M | 395,000 |
| Other Operating Expenses | 3.0M | 3.2M | 3.5M | 2.8M | 823,000 |
| Operating Expense | 3.5M | 6.6M | 4.0M | 5.9M | 1.2M |
| Operating Income | -3.5M | -6.6M | -4.1M | -6.0M | -1.3M |
| EBIT | -3.3M | -5.3M | -2.3M | -5.0M | -960,000 |
| Interest Expense | 14,000 | 15,000 | 16,000 | 15,000 | 16,000 |
| Interest Expense Non Operating | 14,000 | 15,000 | 16,000 | 15,000 | 16,000 |
| Interest Income | 142,000 | 134,000 | 142,000 | 145,000 | 103,000 |
| Interest Income Non Operating | 142,000 | 134,000 | 142,000 | 145,000 | 103,000 |
| Net Interest Income | 128,000 | 119,000 | 126,000 | 130,000 | 87,000 |
| Other Income Expense | 67,000 | 1.1M | 1.6M | 854,000 | 200,000 |
| Other Non Operating Income Expenses | 66,000 | 1.1M | 1.6M | 853,000 | 201,000 |
| Special Income Charges | 0.00 | 11,000 | -- | -- | 0.00 |
| Gain On Sale Of Security | 1,000 | -- | -- | 1,000 | -1,000 |
| Pretax Income | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Income From Continuing Operation Net Minority Interest | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Income Including Noncontrolling Interests | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Income Common Stockholders | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Income | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| EBITDA | -3.3M | -5.3M | -2.2M | -4.9M | -915,000 |
| Normalized EBITDA | -3.3M | -5.3M | -2.2M | -4.9M | -914,000 |
| Reconciled Depreciation | 44,000 | 44,000 | 47,000 | 46,000 | 45,000 |
| Basic EPS | -0.02 | -0.03 | -- | -0.03 | -0.01 |
| Diluted EPS | -0.02 | -0.03 | -- | -0.03 | -0.01 |
| Basic Average Shares | 191.9M | 187.5M | -- | 171.8M | 159.8M |
| Diluted Average Shares | 191.9M | 187.5M | -- | 171.8M | 159.8M |
| Total Unusual Items | 1,000 | 11,000 | -1,000 | 1,000 | -1,000 |
| Total Unusual Items Excluding Goodwill | 1,000 | 11,000 | -1,000 | 1,000 | -1,000 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -3.3M | -5.3M | -2.3M | -5.0M | -975,000 |
| Diluted NI Availto Com Stockholders | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Gain On Sale Of Ppe | 0.00 | 11,000 | -- | -- | 0.00 |
| Insurance And Claims | 37,000 | 43,000 | 38,000 | 174,000 | 32,000 |
| Net Income Continuous Operations | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Non Operating Interest Income Expense | 128,000 | 119,000 | 126,000 | 130,000 | 87,000 |
| Other Gand A | 383,000 | 537,000 | 413,000 | 561,000 | 361,000 |
| Reconciled Cost Of Revenue | 44,000 | 44,000 | 47,000 | 46,000 | 45,000 |
| Salaries And Wages | 14,000 | 2.8M | 16,000 | 2.4M | 2,000 |
| Total Expenses | 3.5M | 6.6M | 4.1M | 6.0M | 1.3M |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 34.3M | 19.3M | 19.5M | 23.7M | 12.2M |
| Cash Cash Equivalents And Short Term Investments | 37.3M | 20.8M | 21.3M | 26.3M | 14.8M |
| Cash Equivalents | 33.4M | 18.8M | 18.7M | 22.9M | 10.8M |
| Cash Financial | 920,000 | 553,000 | 754,000 | 808,000 | 1.5M |
| Other Short Term Investments | 2.9M | 1.4M | 1.8M | 2.6M | 2.6M |
| Receivables | -- | -- | 543,000 | -- | -- |
| Prepaid Assets | 358,000 | 266,000 | -- | 421,000 | 225,000 |
| Current Assets | 37.6M | 21.0M | 21.8M | 26.7M | 15.1M |
| Gross PPE | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M |
| Accumulated Depreciation | -1.5M | -1.5M | -1.5M | -1.4M | -1.4M |
| Net PPE | 1.2M | 1.2M | 1.2M | 1.3M | 1.3M |
| Other Non Current Assets | 6,000 | 6,000 | 64,000 | 64,000 | 64,000 |
| Total Non Current Assets | 1.2M | 1.3M | 1.3M | 1.4M | 1.4M |
| Total Assets | 38.9M | 22.3M | 23.1M | 28.1M | 16.4M |
| Current Debt And Capital Lease Obligation | 119,000 | 116,000 | 114,000 | 111,000 | 104,000 |
| Accounts Payable | 987,000 | 2.5M | 911,000 | 4.4M | 762,000 |
| Payables | 987,000 | 2.5M | 911,000 | 4.4M | 762,000 |
| Payables And Accrued Expenses | 987,000 | 2.5M | 911,000 | 4.4M | 762,000 |
| Current Liabilities | 6.5M | 2.6M | 2.2M | 7.3M | 866,000 |
| Long Term Debt And Capital Lease Obligation | 511,000 | 542,000 | 571,000 | 600,000 | 609,000 |
| Long Term Capital Lease Obligation | 511,000 | 542,000 | 571,000 | 600,000 | 609,000 |
| Total Non Current Liabilities Net Minority Interest | 511,000 | 542,000 | 571,000 | 600,000 | 609,000 |
| Total Liabilities Net Minority Interest | 7.0M | 3.1M | 2.7M | 7.9M | 1.5M |
| Common Stock | 149.7M | 133.8M | 131.5M | 126.7M | 117.9M |
| Capital Stock | 149.7M | 133.8M | 131.5M | 126.7M | 117.9M |
| Retained Earnings | -138.3M | -135.0M | -129.7M | -127.4M | -122.4M |
| Gains Losses Not Affecting Retained Earnings | 20.5M | 20.4M | 18.6M | 20.8M | 19.4M |
| Other Equity Adjustments | 20.5M | 20.4M | 18.6M | 20.8M | 19.4M |
| Common Stock Equity | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Stockholders Equity | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Total Equity Gross Minority Interest | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Total Capitalization | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Net Tangible Assets | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Tangible Book Value | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Working Capital | 31.2M | 18.4M | 19.6M | 19.4M | 14.2M |
| Invested Capital | 31.9M | 19.1M | 20.4M | 20.1M | 15.0M |
| Total Debt | 630,000 | 658,000 | 685,000 | 711,000 | 713,000 |
| Share Issued | 207.5M | 188.8M | 185.5M | 178.5M | 165.1M |
| Ordinary Shares Number | 207.5M | 188.8M | 185.5M | 178.5M | 165.1M |
| Accrued Interest Receivable | -- | -- | 97,000 | -- | -- |
| Capital Lease Obligations | 630,000 | 658,000 | 685,000 | 711,000 | 713,000 |
| Current Capital Lease Obligation | 119,000 | 116,000 | 114,000 | 111,000 | 104,000 |
| Current Deferred Liabilities | 5.4M | 0.00 | 1.1M | 2.8M | 0.00 |
| Machinery Furniture Equipment | 853,000 | 853,000 | 854,000 | 854,000 | 854,000 |
| Other Properties | 987,000 | 987,000 | 987,000 | 987,000 | 963,000 |
| Other Receivables | -- | -- | 145,000 | -- | -- |
| Taxes Receivable | -- | -- | 301,000 | -- | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -4.9M | -1.8M | -8.3M | 91,000 | -2.8M |
| Cash Flow From Continuing Operating Activities | -4.9M | -1.8M | -8.3M | 91,000 | -2.8M |
| Depreciation And Amortization | 44,000 | 44,000 | 47,000 | 46,000 | 45,000 |
| Depreciation Amortization Depletion | 44,000 | 44,000 | 47,000 | 46,000 | 45,000 |
| Stock Based Compensation | 14,000 | 2.8M | 16,000 | 2.4M | 2,000 |
| Change In Working Capital | -1.6M | 1.9M | -3.6M | 3.5M | -346,000 |
| Change In Payables And Accrued Expense | -1.5M | 1.6M | -3.5M | 3.7M | -344,000 |
| Change In Payable | -1.5M | 1.6M | -- | 3.7M | -344,000 |
| Other Non Cash Items | -194,000 | -1.3M | -2.6M | -983,000 | -1.6M |
| Capital Expenditure | -12,000 | -39,000 | -2,000 | -- | -- |
| Purchase Of PPE | -12,000 | -39,000 | -2,000 | 0.00 | -9,000 |
| Net PPE Purchase And Sale | -12,000 | -39,000 | -2,000 | 0.00 | -9,000 |
| Sale Of Investment | 0.00 | 60,000 | 250,000 | 0.00 | 250,000 |
| Net Investment Purchase And Sale | 0.00 | 60,000 | 250,000 | 0.00 | 250,000 |
| Investing Cash Flow | -12,000 | 79,000 | 248,000 | 0.00 | 274,000 |
| Cash Flow From Continuing Investing Activities | -12,000 | 79,000 | 248,000 | 0.00 | 274,000 |
| Repayment Of Debt | -42,000 | -42,000 | -42,000 | -41,000 | -40,000 |
| Net Issuance Payments Of Debt | -42,000 | -42,000 | -42,000 | -41,000 | -40,000 |
| Issuance Of Capital Stock | -- | -- | 0.00 | 9.2M | -- |
| Net Common Stock Issuance | -- | -- | 0.00 | 9.2M | -- |
| Financing Cash Flow | 19.9M | 1.6M | 3.9M | 11.3M | 5.7M |
| Cash Flow From Continuing Financing Activities | 19.9M | 1.6M | 3.9M | 11.3M | 5.7M |
| Effect Of Exchange Rate Changes | 1,000 | 0.00 | -1,000 | 1,000 | -1,000 |
| Changes In Cash | 15.0M | -138,000 | -4.2M | 11.4M | 3.2M |
| Beginning Cash Position | 19.3M | 19.5M | 23.7M | 12.2M | 9.1M |
| End Cash Position | 34.3M | 19.3M | 19.5M | 23.7M | 12.2M |
| Free Cash Flow | -4.9M | -1.9M | -8.3M | 91,000 | -2.8M |
| Asset Impairment Charge | -- | -- | -- | 0.00 | -- |
| Change In Prepaid Assets | -- | 305,000 | -65,000 | -- | -- |
| Common Stock Issuance | -- | -- | 0.00 | 9.2M | -- |
| Depreciation | -- | 44,000 | 47,000 | 46,000 | 45,000 |
| Gain Loss On Sale Of PPE | 0.00 | -11,000 | 0.00 | 0.00 | 0.00 |
| Interest Received Cfo | 142,000 | 105,000 | 85,000 | 145,000 | 103,000 |
| Long Term Debt Payments | -42,000 | -42,000 | -42,000 | -41,000 | -40,000 |
| Net Foreign Currency Exchange Gain Loss | -1,000 | 0.00 | 1,000 | -1,000 | 1,000 |
| Net Income From Continuing Operations | -3.3M | -5.3M | -2.3M | -5.0M | -976,000 |
| Net Long Term Debt Issuance | -42,000 | -42,000 | -42,000 | -41,000 | -40,000 |
| Net Other Investing Changes | 0.00 | 58,000 | 0.00 | 0.00 | -- |
| Operating Gains Losses | -1,000 | -11,000 | -- | -- | -- |
| Proceeds From Stock Option Exercised | 5.9M | 1.7M | 3.9M | 2.1M | 977,000 |